Document Detail


The effect of acebutolol on cardiac arrhythmias in patients with chronic coronary artery disease.
MedLine Citation:
PMID:  6102434     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The effect of the beta-blocking drug acebutolol on the severity of cardiac arrhythmias and the incidence of exercise-induced arrhythmias was studied in 15 patients with chronic coronary artery disease using ambulatory Holter monitoring and bicycle ergometry. We found a significantly lower grading of arrhythmias both on long-term ECGs and during and after exercise. Furthermore, there was a significant decrease in the incidence of VPBs during and after exercise (18.15 +/- 7.7 on placebo vs. 3.46 +/- 1.7 on acebutolol). It is concluded that acebutolol favorably influences the incidence and severity of ventricular arrhythmias in patients with chronic coronary artery disease.
Authors:
D Burckhardt; E A Raeder
Related Documents :
67724 - What does the symptom "palpitation" mean? - correlation between symptoms and the presen...
8627544 - Differential efficacy of the class iii agent mk-499 against programmed stimulation-indu...
3878194 - Diagnosis and treatment of cardiac arrhythmias.
2636814 - Contrastive effects of prostaglandin f2 alpha on normal cardiac rhythm and ouabain-indu...
12500734 - Rapid on-site defibrillation versus community program.
19124424 - Ace-inhibitor, at1-receptor-antagonist, or both? a clinical pharmacologist's perspectiv...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  American heart journal     Volume:  99     ISSN:  0002-8703     ISO Abbreviation:  Am. Heart J.     Publication Date:  1980 Apr 
Date Detail:
Created Date:  1980-05-23     Completed Date:  1980-05-23     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0370465     Medline TA:  Am Heart J     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  443-5     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acebutolol / therapeutic use*
Adrenergic beta-Antagonists*
Aged
Arrhythmias, Cardiac / complications,  drug therapy*
Coronary Disease / complications*
Electrocardiography
Exercise Test
Female
Heart Rate / drug effects
Heart Ventricles / physiopathology
Humans
Male
Middle Aged
Placebos
Chemical
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Placebos; 37517-30-9/Acebutolol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  CT in localization of impalpable cryptorchid testes.
Next Document:  Clinical investigation of terfenadine, a non-sedating antihistamine.